OUR MISSION

enabling scientists, clinicians and patients to fight cancer metastasis more efficiently.

Facilitating Research

Metastasis is responsible for over 90% of cancer-related deaths, making it a critical challenge to address. However, the lack of clinically relevant models poses a significant gap in our understanding.

To address these gaps, we have developed the only microfluidic platform that accurately replicates tumour behaviour within a flow-informed framework. This innovative platform enables the capture of highly metastatic tumour cells, providing a valuable tool for drug discovery and assessing treatment response. 

Precision Medicine

Our clinical testing is aligned with our microfluidic device to enable precision medicine and enhances patient treatment outcomes.

Our goal is to provide innovative solutions that help combat cancer care and improve the standard of care for cancer patients worldwide.